Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Treatment of Non- Hodgkin’s Lymphoma Precursor B cell Lymphoblastic Leukemia • Remission induction with combination therapy • Consolidation phase: – High dose systemic therapy – Treatment to eliminate CNS disease • Continuing therapy: prevent relapse and effect cure Precursor B cell Lymphoblastic Leukemia • Combination therapy used: – Rituximab- fludarabine- cyclophosphamide • Associated with grade III or IV neutropenia – Cyclophophamide- vincristine- prednisone – Cyclophosphamide- doxorubicin- vincristineprednisone B Cell Chronic Lymphoid Leukemia/ Small Lymphocytic Leukemia • Most common: – Chlorambucil: orally; few immediate side effects • Chosen in elderly patients who require therapy – Fludarabine: IV; with significant immune suppression • more active agent; with significant incidence of complete remission • Regimens inclusive of this drug is chosen for young patients presenting with leukemiarequiring therapy • Second line agent for patients with tumors unresponsive to chlorambucin B Cell Chronic Lymphoid Leukemia/ Small Lymphocytic Leukemia • Rai stage O and Binet stage A ( no manifestations of disease other than BM involvement and lymphocytosis – Followed without a specific therapy • With adequate number of circulating normal blood cells, asymptomatic – Require treatment for the first few years of follow up B Cell Chronic Lymphoid Leukemia/ Small Lymphocytic Leukemia • Rai stage III or IV or Binet stage C (Bone Marrow failure) – Require initial therapy – Immune manifestations should be managed independently of antileukemic therapy MALT Lymphoma • Radiation and Surgery – Because it is often localized • Eradication of H. pylori infection • With more extensive diseases: Chlorambucil Mantle Cell Lymphoma • With disseminated disease: aggressive combination chemotherapy regimens+ autologous/ allogeneic BM transplantation • Localized diseases: combination chemotherapy + radiotherapy • Asymptomatic, elderly patient: observation + single- agent chemotherapy Follicular Lymphoma • Asymptomatic patient, older patient: watchful waiting • For those who require treatment: singleagent chlorambucil or cyclophosphamide or combination therapy with CVP or CHOP • For patients with localized follicular lymphoma: radiotherapy Follicular Lymphoma • Most responsive to chemotherapy and radiotherapy • Active therapies: – Fludarabine – Interferon α: prolong survival in patients on doxorubicin- containing combination therapies – Monoclonal antibodies with or without radionuclides – Lymphoma vaccines Diffuse Large B Cell Lymphoma • Initial Treatmant: combination chemotherapy regimen= CHOP + Rituximab – Stage I or non bulky stage II: 3-4 cycles + field radiotherapy – Bulky stage II, stage III, stage IV: 6-8 cycles or 4 cycles then reevaluate -> complete remission -> 2 more cycles, then therapy discontinued Diffuse Large B Cell Lymphoma • IPI : predict favorable responses – Score 0-1: 5 year survival >70 % – Score 4-5: 5 year survival ~20% • For refractory cases or relapse – Salvage therapy – Alternative combination therapy – Autologous bone marrow transplantation Burkitt’s Lymphoma • Treatment should begin 48 hrs after diagnosis • High doses of cyclophosphamide • Prophylactic therapy to CNS mandatory • Hairy cell leukemia: Cladribine • Splenic marginal zone lymphoma: splenectomy, chlorambucil • Lymphoplasmacytic lymphoma: Chlorambucil, fludarabine and cladribine • Nodal marginal zone lymphoma: treatment same as follicular lymphoma Precursor T Cell Lymphoblastic Leukemia • Very intensive remission induction and consolidation regimens • Leukemia- like regimens: for older children and young adults • With high levels of LDH or BM, CNS involvement: BM transplantation Anaplastic Large T/ Null Cell Lymphoma • Treatment regimens same as for other aggressive lymphomas (diffuse large B cell lymphoma) • Rituximab is omitted • Mycoises Fungoides – Localized early stage: radiotherapy- total skin electron beam irradiation – More advanced disease: topical glucocorticoids, topical nitrogen mustard, phototherapy, psoralen with PUVA, electron beam radiation, IFN, Antibodies, fusion toxins and systemic cytotoxic therapy • Adult T Cell Lymphoma/ Leukemia – Combination chemotherapy regimens